Christian S Hendershot

• University of Southern California

  Professor

Sources: reporter.nih.gov

• National Institute on Drug Abuse

  U01, Multi Site Randomized Trial of a GLP-1/GIP Receptor Agonist for Smoking Cessation, U01DA064384, 2025–2028, 18 May 2026

• National Institute on Alcohol Abuse and Alcoholism

  R21, Phase II Evaluation of Tirzepatide in Adults with Alcohol Use Disorder and Overweight or Obesity, R21AA031892, 2024–2026, 5 Sept 2025

Sources: reporter.nih.gov